first-line tagraxofusp followed by allosct in bpdcn: a case study
Published 4 months ago • 156 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:44
long-term results from a trial of tag in patients with bpdcn
-
4:18
phase 1 - import models
-
1:09
early results from epcore cll-1 trial: subcutaneous epcoritamab in patients with richter’s syndrome
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
11:01
legendplex™ laboratory protocol video
-
3:19
first-line treatment selection in myelofibrosis
-
1:56
ibrutinib plus venetoclax for first-line treatment of cll: 4-year follow-up data
-
3:02
euplagia-1: phase i trial of glpg5201, a cd19 car-t product, in r/r cll and richter's transformation
-
2:55
post-transplant pd1 blockade plus autologous lymphocytes in r/r hl
-
0:30
ultrasound guided s1 transforaminal block (linear probe)
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
2:20
ephb1 and efnb2 in pws vascular dilatation, w. tan et al
-
2:16
the role of covalent btkis in the management of cll
-
2:03
invitrogen lyo-ready bst dna polymerase
-
0:51
lab-grown red blood cells transfused in to a person for first time
-
5:23
set up installation
-
5:18
labpronto: dentist interface to track up-to-date order information
-
1:25
preliminary results from a phase ib trial of as-1763, a novel non-covalent btki, in cll/mcl
-
0:33
microinjection dextran red and gfp mrna into mcf7 cells on etaluma ls720 by zambon lab at kgi